Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kini

Showing results (211-220 of 250) with videos related to

Pageof 25
Sort By:
The American Journal of Cardiology|February 20, 2025
Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective RegistrySean Gilhooley, David Power, Anastasios Roumeliotis, et al.
European Heart Journal. Digital Health|January 30, 2023
Mobile application to optimize care for ST-segment elevation myocardial infarction patients in a large healthcare system, STEMIcathAID: rationale and designParasuram Krishnamoorthy, Andriy Vengrenyuk, Brian Wasielewski, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
Journal of the American College of Cardiology|September 20, 2011
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trialsUsman Baber, Roxana Mehran, Samin K Sharma, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2022
Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuliGilbert H L Tang, Amit Hooda, Syed Zaid, et al.
American Heart Journal|July 2, 2022
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation projectHaydee Garcia, Bernadette Springer, Andriy Vengrenyuk, et al.
Circulation. Cardiovascular Interventions|September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)Binita Shah, Usman Baber, Stuart J Pocock, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
Journal of the American Heart Association|May 31, 2024
Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft SurgeryAnoop N Koshy, Gregg W Stone, Samantha Sartori, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
Pageof 25

Showing results (211-220 of 250) with videos related to

Sort By:
Pageof 25
The American Journal of Cardiology|February 20, 2025
Treatment of Additional Vessels During Percutaneous Coronary Intervention for Unprotected Left Main Disease: Insights From a Large Prospective RegistrySean Gilhooley, David Power, Anastasios Roumeliotis, et al.
European Heart Journal. Digital Health|January 30, 2023
Mobile application to optimize care for ST-segment elevation myocardial infarction patients in a large healthcare system, STEMIcathAID: rationale and designParasuram Krishnamoorthy, Andriy Vengrenyuk, Brian Wasielewski, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
Journal of the American College of Cardiology|September 20, 2011
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trialsUsman Baber, Roxana Mehran, Samin K Sharma, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2022
Outcomes and feasibility of redo-TAVR after Sapien 3 Ultra TAVR in extremely-undersized versus nominally-sized annuliGilbert H L Tang, Amit Hooda, Syed Zaid, et al.
American Heart Journal|July 2, 2022
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation projectHaydee Garcia, Bernadette Springer, Andriy Vengrenyuk, et al.
Circulation. Cardiovascular Interventions|September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)Binita Shah, Usman Baber, Stuart J Pocock, et al.
Journal of Thrombosis and Thrombolysis|March 30, 2019
Associations between use of prasugrel vs clopidogrel and outcomes by type of acute coronary syndrome: an analysis from the PROMETHEUS registryZhen Ge, Usman Baber, Bimmer E Claessen, et al.
Journal of the American Heart Association|May 31, 2024
Outcomes Following Percutaneous Coronary Intervention in Patients With Multivessel Disease Who Were Recommended for But Declined Coronary Artery Bypass Graft SurgeryAnoop N Koshy, Gregg W Stone, Samantha Sartori, et al.
Journal of the American College of Cardiology|April 16, 2016
Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARISUsman Baber, Roxana Mehran, Gennaro Giustino, et al.
Pageof 25